Influence of a Lubricating Gel (Orthospeed®) on Pain and Oral Health-Related Quality of Life in Orthodontic Patients during Initial Therapy with Conventional and Low-Friction Brackets: A Prospective Randomized Clinical Trial.

The aim of this study was to investigate whether statistically significant differences exist regarding pain and the impact on oral quality of life of orthodontic treatment. A conventional brackets system was compared with low-friction brackets. A total of 90 patients (male = 35, female = 55) were chosen for this randomized clinical trial. Pain was assessed at 4, 8, and 24 hours and 2, 3, 4, 5, 6, and 7 days after the start of treatment using the McGill Pain Questionnaire. Oral health-related quality of life (OHRQoL) was assessed using the Oral Health Impact Profile-14 (OHIP-14) questionnaire. Oral quality of life was assessed at one month, with patients with low-friction brackets describing lower levels of pain. The patients with conventional brackets indicated a worse impact on their quality of life compared to the group with low-friction brackets. Statistically significant differences were found between the groups, with maximum pain observed between the first 24 and 48 hours, and the values of minimum pain are reached after 7 days. The pain and impact on oral quality of life was statistically worse in patients with conventional brackets compared to patients with low-friction brackets. The type of bracket system used was therefore shown to influence patients' perceptions of pain and impact on their OHRQoL.

Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.

BACKGROUND: A new group of oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years. Patients being treated with oral anticoagulants are at higher risk for bleeding when undergoing dental treatments. MATERIAL AND METHODS: A literature search was conducted through April 2016 for publications in the ISI Web of Knowledge, PubMed and Cochrane Library using the keywords "dabigatran", "rivaroxaban", "apixaban", "edoxaban", "new oral anticoagulants", "novel oral anticoagulants", "bleeding" and "dental treatment". RESULTS: There is no need for regular coagulation monitoring of patients on dabigatran therapy. Whether or not to temporarily discontinue dabigatran must be assessed according to the bleeding risk involved in the dental procedure to be performed. CONCLUSIONS: The number of patients under treatment with new oral anticoagulants will increase in the coming years. It is essential to know about the pharmacokinetics and pharmacodynamics of new oral anticoagulants and about their interactions with other drugs. It is necessary to develop clinical guidelines for the perioperative and postoperative management of these new oral anticoagulants in oral surgical procedures, and to carefully evaluate the bleeding risk of dental treatment, as well as the thrombotic risk of suppressing the new oral anticoagulant. Key words:Dabigatran, rivaroxaban, apixaban, edoxaban, novel oral anticoagulants, bleeding.

[Isokinetic evaluation of the muscular strength and balance of knee extensor and flexor apparatus of taekwondo athletes]. / Valoración isocinética de la fuerza y balance muscular del aparato extensor y flexor de la rodilla en taekwondoines.

UNLABELLED: Lower limb strength and muscular balance are important attributes in the practice of Taekwondo. OBJECTIVE: To assess through isokinetic dynamometry the muscular strength and balance of knee extensor and flexor apparatus of elite Taekwondo athletes and to compare with recreational-type athletes. METHODS: The maximum torque, the angle of maximum torque, maximum torque work, total work of the series, average power, and flexor and extensor muscle apparatus balance of the knees were obtained. RESULTS: A total of 32 knees were studied. Significantly higher values in peak torque and total work of the series were present in the group of TKD athletes in the extensor muscles, while the maximum torque angle of extensor and flexor muscles was higher in controls. We found a muscular imbalance due to flexor muscle strength deficit in both groups. CONCLUSIONS: Higher levels of muscular strength and an imbalance between the knee flexor and extensor muscle groups characterized the predominant motor gesture of TKD athletes. These results are useful in the design and implementation of training programs, to optimize the value of muscular strength and muscle balance in TKD athletes directed to promote optimal athletic performance and prevent sport-related injuries.

Adenosina induce arritmias ventriculares en corazones con miocardiopatía chagásica crónica / Adenosine induces ventricular arrythmias in hearts with chronic chagas cardiomyopathy

La adenosina liberada durante la isquemia y la hipoxia es capaz de inducir arritmias ventriculares, fenómenos también observados en la enfermedad de Chagas. En este trabajo caracterizamos farmacológicamente las propiedades arritmogénicas de la adenosina en ratas Sprague Dawley sanas (n = 14) y con miocarditis chagásica crónica (n = 14), que fueron sometidas a estudios electrocardiográficos y farmacológicos en preparaciones de corazón aislado tipo Langendorff. La adenosina incrementó las arritmias ventriculares en ambos grupos en forma dosis-dependiente, y en un 50% de las ratas chagásicas indujo fibrilación ventricular respecto a un 7,14% de las ratas sanas (p < 0,05). La fibrilación fue prevenida por antagonistas A1 (DPCPX) y A2a (8-CSC). Las arritmias se asociaron a un QT prolongado, a depolarizaciones tempranas, a fenómenos R sobre T y torsade de pointes. En conclusión, la adenosina es un fármaco proarrítmico capaz de inducir fibrilación ventricular en ratas chagásicas (AU)

Adenosine released during ischemia and hypoxia can induce ventricular arrhythmias. This phenomenon is also observed in Chagas disease. This study involved pharmacologic analysis of the arrhythmogenic properties of adenosine in healthy Sprague-Dawley rats (n=14) and in rats with chronic Chagas cardiomyopathy (n=14). Electrocardiographic and pharmacologic studies were performed on isolated hearts prepared using the Langendorff method. Adenosine increased ventricular arrhythmias in both groups of animals in a dose-dependent manner: 50% of chagasic rats developed ventricular fibrillation compared with 7.14% of healthy rats (P < .05). Fibrillation was prevented by A1 (i.e., DPCPX) and A2a (i.e., 8-CSC) receptor antagonists. Arrhythmia was associated with a prolonged QT interval, early depolarization, and the R-on-T and torsade de pointes phenomena. In conclusion, adenosine is a proarrythmic drug that is able to induce ventricular fibrillation in chagasic rat hearts (AU)

[Adenosine induces ventricular arrythmias in hearts with chronic chagas cardiomyopathy]. / Adenosina induce arritmias ventriculares en corazones con miocardiopatía chagásica crónica.

Adenosine released during ischemia and hypoxia can induce ventricular arrhythmias. This phenomenon is also observed in Chagas disease. This study involved pharmacologic analysis of the arrhythmogenic properties of adenosine in healthy Sprague-Dawley rats (n=14) and in rats with chronic Chagas cardiomyopathy (n=14). Electrocardiographic and pharmacologic studies were performed on isolated hearts prepared using the Langendorff method. Adenosine increased ventricular arrhythmias in both groups of animals in a dose-dependent manner: 50% of chagasic rats developed ventricular fibrillation compared with 7.14% of healthy rats (P< .05). Fibrillation was prevented by A1 (i.e., DPCPX) and A2a (i.e., 8-CSC) receptor antagonists. Arrhythmia was associated with a prolonged QT interval, early depolarization, and the R-on-T and torsade de pointes phenomena. In conclusion, adenosine is a proarrythmic drug that is able to induce ventricular fibrillation in chagasic rat hearts.